Estrogen Therapy Risks Links

Ask Dr. Weil: Role of hormones in cancer of prostate (Arizona Daily Star)

Q I cannot understand how experts can have such opposing views concerning the roles of testosterone and estrogen in prostate cancer. What is your opinion on the issue of male hormone replacement?

Cougar Biotechnology Announces Initiation of Phase I/II Trial of CB7630 (Abiraterone Acetate) in Advanced Breast ... (Business Wire via Yahoo! Finance)

LOS ANGELES----Cougar Biotechnology, Inc. today announced that the first patient was enrolled in a Phase I/II clinical trial of the Company’s drug candidate CB7630 , an orally active inhibitor of the steroidal enzyme 17alpha-hydroxylase/C17,20 lyase, for the treatment of advanced breast cancer.

FDA Approves Low-dose Regimen Of Premarin Vaginal Cream To Treat Moderate To Severe Postmenopausal Dyspareunia Painful ... (Medical News Today)

PREMARIN® (conjugated estrogens) Vaginal Cream 0.5 g has been approved by the U.S. Food and Drug Administration (FDA) for a new indication and a new less frequent twice-weekly dosing regimen to treat moderate to severe postmenopausal dyspareunia (painful sexual intercourse) announced Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE).

Testosterone Effective In Female Sexual Dysfunction; BioSante Conducting Long-Term Safety Study Of LibiGel(R) In FSD (Medical News Today)

BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX), a specialty pharmaceutical company focused on developing products for female sexual health, menopause, contraception, and male hypogonadism, commented today on a new publication reporting on the efficacy of testosterone in the treatment of Female Sexual Dysfunction (FSD), specifically hypoactive sexual desire disorder (HSDD) in menopausal women.

Premarin Vaginal Cream FDA-Approved for Dyspareunia (Painful Intercourse) (PR.com)

The FDA has approved Premarin Vaginal Cream as the first prescription vaginal cream for postmenopausal dyspareunia (painful sexual intercourse). [PR.com - November 13, 2008]